Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析

◆英語タイトル:Psychemedics Corp (PMD) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14814
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Psychemedics Corp (Psychemedics) is a clinical laboratory service provider. The company provides testing for drugs abuse using hair analysis. It offers drug panel, workplace drug testing, personal drug testing kits, school drug testing, alcohol testing, synthetic cannabinoids testing, benzodiazepines testing, instant testing, and contractor compliance. Psychemedics’ technologies include the importance of effective drug testing, the science behind hair analysis, urinalysis testing, and hair testing process. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and small to mid-size corporations. It has presence in Turkey and the US. Psychemedics is headquartered in Acton, Massachusetts, the US.

Psychemedics Corp Key Recent Developments

Mar 04,2019: Psychemedics announces 3rd straight year of record revenue; declares 90th consecutive quarterly dividend
Oct 23,2018: Psychemedics announces quarterly results
Jul 24,2018: Psychemedics announces 2Q record revenues
May 08,2018: James Abely Promoted to VP and General Counsel at Psychemedics Corporation
May 02,2018: Psychemedics Announces New Vice President, Sales and Marketing

This comprehensive SWOT profile of Psychemedics Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Psychemedics Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Psychemedics Corp – Key Information
Psychemedics Corp – Overview
Psychemedics Corp – Key Employees
Psychemedics Corp – Key Employee Biographies
Psychemedics Corp – Key Operational Heads
Psychemedics Corp – Major Products and Services
Psychemedics Corp – History
Psychemedics Corp – Company Statement
Psychemedics Corp – Locations And Subsidiaries
Psychemedics Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Psychemedics Corp – Business Description
Psychemedics Corp – Corporate Strategy
Psychemedics Corp – SWOT Analysis
SWOT Analysis – Overview
Psychemedics Corp – Strengths
Psychemedics Corp – Weaknesses
Psychemedics Corp – Opportunities
Psychemedics Corp – Threats
Psychemedics Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Psychemedics Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Psychemedics Corp, Key Information
Psychemedics Corp, Key Ratios
Psychemedics Corp, Share Data
Psychemedics Corp, Major Products and Services
Psychemedics Corp, History
Psychemedics Corp, Key Employees
Psychemedics Corp, Key Employee Biographies
Psychemedics Corp, Key Operational Heads
Psychemedics Corp, Other Locations
Psychemedics Corp, Subsidiaries
Psychemedics Corp, Key Manufacturing facilities
Psychemedics Corp, Key Competitors
Psychemedics Corp, SWOT Analysis
Psychemedics Corp, Ratios based on current share price
Psychemedics Corp, Annual Ratios
Psychemedics Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Psychemedics Corp, Performance Chart
Psychemedics Corp, Ratio Charts

★海外企業調査レポート[Psychemedics Corp (PMD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Driver Group Plc (DRV):企業の財務・戦略的SWOT分析
    Driver Group Plc (DRV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Toyo Engineering Corp:企業の戦略・SWOT・財務分析
    Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report Summary Toyo Engineering Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Woori Bank:企業のM&A・事業提携・投資動向
    Woori Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Woori Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Punj Lloyd Ltd (PUNJLLOYD):企業の財務・戦略的SWOT分析
    Punj Lloyd Ltd (PUNJLLOYD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Okinawa Cellular Telephone Company (9436):企業の財務・戦略的SWOT分析
    Okinawa Cellular Telephone Company (9436) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Ocular Therapeutix Inc (OCUL):企業の製品パイプライン分析2018
    Summary Ocular Therapeutix Inc (Ocular), formerly I-Therapeutix Inc is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for diseases using hydrogel platform technology. The company’s products include DEXTENZA, sustained release travoprost and posterior …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • First Republic Bank:企業のM&A・事業提携・投資動向
    First Republic Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Republic Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Bumi Armada Bhd (ARMADA):石油・ガス:M&Aディール及び事業提携情報
    Summary Bumi Armada Bhd (Bumi Armada) is an integrated offshore solutions provider. The company owns and operates Floating Production Storage & Offloading (FPSO), Offshore Support Vessels (OSV), pipelaying barges, and subsea vessels. Its FPSO portfolio includes Armada TGT 1, Armada Sterling, Armada …
  • Syndax Pharmaceuticals Inc (SNDX)-医療機器分野:企業M&A・提携分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is aclinical stage biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate, entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for t …
  • CASI Pharmaceuticals Inc (CASI):製薬・医療:M&Aディール及び事業提携情報
    Summary CASI Pharmaceuticals Inc (CASI) is a biopharmaceutical company, which focuses on the acquisition, development and commercialization of innovative therapies for treating cancer and other unmet medical needs. Its pipeline product portfolio includes ENMD-2076 that is being developed globally fo …
  • Diazyme Laboratories Inc:製品パイプライン分析
    Summary Diazyme Laboratories Inc (Diazyme Laboratories) is a developer of diagnostic reagents. The company’s products include vitamin D assays, vitamin D assay for clinical chemistry analyzers, adenosine deaminase assay, cardiac troponin I assay, creatinine assay, D-dimer assay, direct enzymatic HbA …
  • Koninklijke Ten Cate NV:企業の戦略的SWOT分析
    Koninklijke Ten Cate NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Laboratory Corp of America Holdings (LH)-医療機器分野:企業M&A・提携分析
    Summary Laboratory Corp of America Holdings (LabCorp) is a provider of clinical laboratory services and end-to-end drug development support. It focuses on the development and commercialization of a wide range of diagnostic technologies and testing services. The company offers clinical diagnostics la …
  • Wesfarmers Limited:企業の戦略・SWOT・財務情報
    Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report Summary Wesfarmers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sigma Pharmaceuticals Limited:戦略・SWOT・企業財務分析
    Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report Summary Sigma Pharmaceuticals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Taiwan Cooperative Bank, Ltd.:企業の戦略・SWOT・財務情報
    Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Taiwan Cooperative Bank, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Humanigen Inc (HGEN)-製薬・医療分野:企業M&A・提携分析
    Summary Humanigen Inc(Humanigen) formerly known as KaloBios Pharmaceuticals Inc, is a development stage biopharmaceutical company that develops medicines for neglected and rare diseases. The company offers benznidazole, a nitroimidazole derivative used for the treatment of Chagas disease, a parasiti …
  • Epic Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Pharma LLC (Epic Pharma), a subsidiary of Humanwell Healthcare (Group) Co Ltd is a drug development company that manufactures and develops generic prescription drugs. The company’s products include amlodipine besylate, citalopram, betaxolol, nicardipine hydrochloride, guanfacine hydroch …
  • Precipio Inc (TBIO):企業の財務・戦略的SWOT分析
    Summary Precipio Inc (Precipio), formerly known as Transgenomic Inc, develops diagnostic tools. The company advances personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. Precipio uses ICE COLD-P …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆